Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
Clinical trial NCT01952015 · COMPLETED
Trial details
- NCT number
- NCT01952015
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-21
- Primary completion
- 2016-03-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.